Latest Harvard Bioscience (HBIO) Headlines Harvard

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Harvard Bioscience (HBIO) Headlines

Harvard Bioscience Names Ronald Aplin to Vice President Global Operations and Quality
GlobeNewswire - Mon Mar 10, 6:13AM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has named Ronald Aplin to Vice President Global Operations and Quality, effective immediately. This is a newly created position.

Nasdaq stocks posting largest volume increases
AP - Mon Mar 03, 5:05PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:

Harvard Bioscience Reports Fourth Quarter and Year-End 2013 Results
GlobeNewswire - Thu Feb 27, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of specialized products to advance life science research, today reported financial highlights for the fourth quarter and full year ended December 31, 2013.

Harvard Bioscience Schedules Fourth Quarter and Year-End 2013 Conference Call for February 27, 2014 at 11:00 AM ET
GlobeNewswire - Fri Feb 14, 6:30AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, will announce results for its fourth quarter and year ended December 31, 2013 before market trading hours on Thursday, February 27, 2014. A conference call to discuss the company's fourth quarter and year-end financial results is scheduled for that same day at 11:00 AM ET.

Harvard Bioscience Realigns Global Operations to Create Organizational Efficiencies and Better Position It for Growth
GlobeNewswire - Wed Dec 04, 6:00AM CST
-Reallocating Resources to Higher-Growth Areas-

Upgrade Alert for Harvard Bioscience (HBIO)
Comtex SmarTrend(R) - Wed Nov 27, 7:04AM CST
Harvard Bioscience (NASDAQ:HBIO) was upgraded from Neutral to Buy at Sidoti today. The stock closed yesterday at $4.47 on volume of 393,000 shares, above average daily volume of 202,000. In the past 52 weeks, Harvard Bioscience share prices have been bracketed by a low of $3.45 and a high of $6.26 and closed yesterday at $4.47, 30% above that low price. The 200-day and 50-day moving averages have moved 0.29% lower and 1.21% lower over the past week, respectively.

Harvard Bioscience Announces Inducement Grants to Recently Hired Executives
GlobeNewswire - Mon Nov 18, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has granted the inducement stock option grants it was obligated to grant to its recently hired executives as follows:

Harvard Bioscience Announces Allocation of Tax Basis for Spin-Off of Harvard Apparatus Regenerative Technology
GlobeNewswire - Wed Nov 13, 10:29AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, announced the allocation of tax basis resulting from the tax-free spin-off of Harvard Apparatus Regenerative Technology, Inc. Based on the relative fair market values of the respective companies on November 1, 2013, the first day of trading after distribution, 23.63 percent of a stockholder`s pre-distribution tax basis in Harvard Bioscience common stock should be allocated to the shares of common stock in Harvard Apparatus Regenerative Technology received pursuant to the distribution described in the Information Statement of Harvard Apparatus Regenerative Technology dated October 17, 2013.

Kellogg and BlackBerry are big market movers
AP - Mon Nov 04, 3:37PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:

Harvard Bioscience completes HART unit spinoff
AP - Mon Nov 04, 9:49AM CST
NEW YORK (AP) — Medical instruments maker Harvard Bioscience said Monday the spinoff of its Harvard Apparatus Regenerative Technology unit is complete.

Jeffrey A. Duchemin Appointed to Additional Roles of President and Director of Harvard Bioscience
GlobeNewswire - Mon Nov 04, 6:15AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that its Chief Executive Officer, Jeffrey A. Duchemin, has been appointed by the Board of Directors to the additional positions of President and Director, effective immediately. He replaces David Green, who has become President at Harvard Apparatus Regenerative Technology, Inc. (HART), which was spun off from HBIO on November 1, 2013. Mr. Green will remain on the Board of Directors of Harvard Bioscience.

Harvard Bioscience Becomes Pure-Play Developer, Manufacturer and Marketer of Tools for Life Science Research
GlobeNewswire - Mon Nov 04, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO) became a pure-play global developer, manufacturer and marketer of a broad range of tools to advance life science research on November 1, 2013. This development resulted as the previously announced spin-off of its former wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, or HART, was completed as of 12:01 a.m. on November 1, 2013.

Harvard Bioscience Reports Third Quarter 2013 Results
GlobeNewswire - Thu Oct 31, 6:00AM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial results for the three and nine months ended September 30, 2013.

Harvard Bioscience Appoints Yong Sun as VP Strategic Marketing and Business Development
GlobeNewswire - Mon Oct 28, 6:00AM CDT
Nearly 20 Years Marketing Experience to Bolster Company's Future Expansion Into Asia and Emerging Markets

Five-Year Follow-Up of World's First Regenerated Trachea Transplant Published in The Lancet
GlobeNewswire - Wed Oct 23, 6:00AM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO) and Harvard Apparatus Regenerative Technology (Nasdaq:HARTV) jointly announce that five years after a 30-year-old woman was implanted with the world's first tissue-engineered trachea grown in a bioreactor she lives complication-free, according to an article published October 23 in The Lancet.

Harvard Bioscience, Inc. Schedules Third Quarter 2013 Conference Call for October 31, 2013 at 11:00 AM ET
GlobeNewswire - Tue Oct 22, 2:40PM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, will announce results for its third quarter ended September 30, 2013 before market trading hours on Thursday, October 31, 2013. A conference call to discuss the company's third quarter financial results is scheduled for that same day at 11:00 AM ET.

Harvard Bioscience Inc elects Yoav Sibony as VP its Global Sales
M2 - Mon Oct 21, 7:28AM CDT
Regenerative medicine company Harvard Bioscience Inc (NasdaqGM:HBIO) revealed on Monday the appointment of Yoav Sibony to the newly created position of vice president of its Global Sales.

Harvard Bioscience Appoints Yoav Sibony as VP Global Sales
GlobeNewswire - Mon Oct 21, 6:00AM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that it has hired Yoav Sibony, a veteran sales manager, as Harvard Bioscience's Vice President of Global Sales, a newly created position, effective October 21.

HBIO Announces Details of Approved Spin-Off of Harvard Apparatus Regenerative Technology, Inc.
GlobeNewswire - Wed Oct 16, 6:10AM CDT
The Board of Directors of Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has approved the spin-off of its wholly owned regenerative medicine device subsidiary, Harvard Apparatus Regenerative Technology, Inc., or HART.

Harvard Bioscience Names Robert E. Gagnon as Chief Financial Officer
GlobeNewswire - Wed Oct 16, 6:00AM CDT
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has hired Robert E. Gagnon, a veteran financial executive, as Harvard Bioscience's Chief Financial Officer, effective as of the date of HBIO's planned spin-off of Harvard Apparatus Regenerative Technology, Inc., or HART, which is anticipated to be November 1, 2013, or the Distribution Date. From October 23, 2013 until the Distribution Date, Mr. Gagnon will initially serve as HBIO's Executive Vice President - Finance.

Harvard Bioscience (HBIO) Stock Research Links

HBIO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 89

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
Minno Bets on Listener Kids to Build Premium Growth

Updated Category News Views 97

Children’s media rarely gets a clean strategic move, but this one comes pretty close. Minno has signed a worldwide, multi-year agreement making it the exclusive faith-based streaming home for Listener Kids’ video library, while commissioning 66 new episodes for its own service. For a company trying to build a serious Christian family-media business, that is more than...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
UnitedHealth’s CMS Audit Shock Puts Disclosures Under Lens

Updated Category News Views 62

Medicare Advantage's audit bill just landed with a nasty thud. UnitedHealth Group shares fell more than 10% on November 18 after the Centers for Medicare & Medicaid Services proposed new anti-fraud, audit, and repayment rules for the program. For holders of NYSE:UNH, this was not some sleepy policy memo buried in a federal filing cabinet. It was a hard reminder that...

Continue Reading
First Horizon Opens Its Charlotte Office in South End

Updated Category News Views 20

A Building Is Not a Balance Sheet Charlotte got a fresh First Horizon sign at 110 East Boulevard on Nov. 19, 2026, and that is a sensible move, not a magic trick. The bank has officially opened a corporate office in the city’s South End neighborhood, positioning the team to develop client relationships across the Charlotte area and broaden its regional footprint. That...

Continue Reading
SwitchBot's Black Friday Sale Tests Smart Home Demand

Updated Category News Views 112

Holiday gadget season is where clever home-tech pitches either earn their keep or gather dust in a warehouse. SwitchBot is coming into Black Friday 2026 with discounts of up to 50% on select products, running from November 19 through Cyber Monday on November 30. The lineup is broad enough to matter: decorative color E Ink frames, automated curtains and blinds, an indoor...

Continue Reading
Honda Prelude’s Hybrid Return Tests a Narrow Niche

Updated Category News Views 22

A low-slung coupe showing up in Newfoundland is not exactly a volume-sales thunderclap, and that is precisely why the 2027 Honda Prelude deserves a closer look. Steele Honda in St. John’s is presenting the hybrid two-door as a fresh choice for buyers who want something livelier than the usual practical commuter. For Honda, and for investors watching Honda Motor Co....

Continue Reading
Thanksgiving Kitchen Safety Is No Place for Autopilot

Updated Category News Views 87

Steam, chatter, and one forgotten burner can turn a holiday meal ugly in a hurry. The Consumer Product Safety Commission’s Nov. 19, 2026 reminder lands on a point that should not need repeating, yet plainly does: Thanksgiving kitchens demand attention, not casual optimism. This is not about ruining anybody’s celebration with a lecture. It is about recognizing that a...

Continue Reading
RBC Signals Gets $10 Million to Push Space Infrastructure

Updated Category News Views 102

Ground stations are the unglamorous plumbing of the space economy, and somebody finally put fresh capital behind the wrench. RBC Signals says it has received a $10 million strategic growth investment led by Washington Harbour Partners, aimed at enlarging its government-services operation and pushing several newer space-connectivity tools toward commercial use. This is a...

Continue Reading
Borr’s Q3 Presentation Puts Jack-Up Investors on Watch

Updated Category News Views 93

Jack-up drilling is a rough business to judge from a calendar invite, but Borr Drilling has put a useful marker in the sand. The company is scheduled to present financial results for the three and nine months ended September 30, 2026, at 09:00 New York time, or 15:00 CET, on Thursday, November 19. For holders of BORR, this is less about ceremonial webcast chatter and more...

Continue Reading

Top 5 Most Recently Viewed Articles

Alstom Expands High-Speed Rail in Morocco with Avelia Trains

Updated Category News Views 422

Alstom Enhances Moroccan Rail Network Alstom, a leader in innovative transportation solutions, has announced an exciting partnership with the Moroccan National Railway Office to supply a fleet of 18 state-of-the-art Avelia Horizon high-speed trains. This €781 million investment marks a significant milestone for both Alstom and Morocco, as it aims to improve rail...

Continue Reading
Freddie Mac's Innovative Offering of $707 Million in Loans

Updated Category News Views 157

Freddie Mac Launches New Securitization Initiative MCLEAN, Va. — Freddie Mac (OTCQB: FMCC) has taken a significant step in bolstering its financial strategies with the announcement of its latest securitization of approximately $707 million. This initiative focuses on re-performing loans (RPLs) and is part of Freddie Mac's ongoing efforts to manage its mortgage-related...

Continue Reading
Innovative Partnership for Sustainable Aviation Fuel Production

Updated Category News Views 251

Exploring New Horizons in Sustainable Aviation Fuel In a groundbreaking collaboration, Haffner Energy, LanzaJet, and LanzaTech have come together to pave the way for the production of Sustainable Aviation Fuel (SAF) from biomass residues. These three industry leaders are equipped with complementary technologies that can significantly enhance the SAF production value...

Continue Reading
Exploring Microchip Technology's Advancements at UBS Conference

Updated Category News Views 175

Microchip Technology's Presentation Highlights at UBS Conference Microchip Technology Incorporated, a prominent figure in the embedded solutions arena, has something exciting planned at an upcoming event. The company, identified by its ticker symbol NASDAQ:MCHP, is preparing to showcase its innovative offerings at the UBS Global Technology and AI Conference. This...

Continue Reading
Bonaccord Capital Partners Achieves $1.6 Billion Milestone

Updated Category News Views 285

Bonaccord Capital Partners Secures $1.6 Billion for BCP II DALLAS — P10, Inc. (NYSE: PX), a distinguished player in private markets solutions, proudly announced the successful closure of its Bonaccord Capital Partners II fund with an impressive $1.6 billion in commitments. This achievement not only surpasses the fund's initial target of $1.25 billion but also marks a...

Continue Reading